Skip to main content
  • Original Article
  • Open access
  • Published:

Serum proteomic pattern for predicting recurrence of undifferentiated nasopharyngeal carcinoma after radiotherapy

A potential surrogate marker

Abstract

Although most patients with early-stage nasopharyngeal carcinoma (NPC) can be cured by radiotherapy, there is a high recurrence rate in patients with advanced NPC. We attempted to identify proteomic patterns in sera for predicting tumor recurrence. Pretreatment sera were collected from 64 NPC patients with complete remission after radiotherapy. Serum proteins were profiled by SELDI ProteinChip technology, and correlated with local/distant recurrence.

Forty proteomic features were significantly different between the patient groups with and without tumor recurrence. Univariate analyses showed that 32 of them were significantly associated with time to first recurrence. Multivariate Cox-regression analyses identified International Union Against Cancer (UICC) stage and two proteomic features with mass/charge (m/z) values of 8808 and 6626 as independent prognostic indicators for tumor recurrence. The hazard ratios were 2.0 (95% confidence interval, CI 1.3–3.2) and 0.79 (95% CI 0.64–0.96) for a double of peak intensity of proteomic feature m/z 8808 and m/z 6626, respectively. These two proteomic features were also independent prognosticators for overall survival. A decision tree was constructed to predict the tumor recurrence by using UICC stage, proteomic feature m/z 8808, and proteomic feature m/z 6626, and evaluated by Leave-One-Out crossvalidation. Kaplan-Meier analysis confirmed that the decision tree could predict both recurrencefree survival and overall survival. The positive and negative predictive values for tumor recurrence within 4 yr were 74 and 89%, respectively.

A serum proteomic pattern comprising features m/z 8808 and m/z 6626 is a potential surrogate marker of disease recurrence after radiotherapy in NPC.

References

  1. Ho, J.H.C. (1978) An epidemiologic and clinical study of nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Bio. Phys. 4:183–205.

    Google Scholar 

  2. Teo, P.M., Yu, P., Lee, W.Y., Leung, S.F., Kwan, W.H., Yu, K.H., et al. (1996) Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int. J. Radiat. Oncol. Biol. Phys. 36:291–304.

    Article  PubMed  CAS  Google Scholar 

  3. Petricoin III, E.F., Ardekani, A.M., Hitt, A.B., Levine, P.J., Fusaro, V.A., Steinberg, S.M., et al. (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359:572–577.

    Article  PubMed  CAS  Google Scholar 

  4. Poon, T.C.W., Yip, T.T., Chan, A.T.C., Yip, C., Yip, V., Mok, T.S.K., et al. (2003) Comprehensive proteomic profiling identifies serum preteomic signatures for detection of hepatocellular carcinoma and its subtypes. Clin. Chem. 49:752–760.

    Article  PubMed  CAS  Google Scholar 

  5. Poon, T.C.W., Chan, K.C.A., Ng, P.C., Chiu, R.W.K., Ang, I.L., Tong, Y.K., et al. (2004) Serial analysis of plasma proteomic signatures in pediatric patients with severe acute respiratory syndrome and correlation with viral load. Clin. Chem. 50:1452–1455.

    Article  PubMed  CAS  Google Scholar 

  6. Poon, T.C.W., Hui, A.Y., Chan, H.L.Y., Ang, I.L., Chow, S.M., Wong, N., et al. (2005) Prediction of liver fibrosis and cirrhosis in chronic Hepatitis B Infection by serum proteomic Fingerprinting: a pilot study. Clin Chem. in press.

  7. Cho, W.C., Yipm, T.T., Yip, C., Yip, V., Thulasiraman, V., Ngan, R.K.C., et al. (2004) Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clin. Cancer Res. 10:43–52.

    Article  PubMed  CAS  Google Scholar 

  8. Xiao, Z., Luke, B.T., Izmirlian, G., Umar, A., Lynch, P.M., Phillips, R.K., et al. (2004) Serum proteomic profiles suggest celecoxibmodulated targets and response predictors. Cancer Res. 64:2904–2909.

    Article  PubMed  CAS  Google Scholar 

  9. Breiman, L., Friedman, J.H., Olshen, R.A., and Stone, G.J. (1984) Classification and regression trees. In The Wadsworth Statistics/Probability Series. (Bickel, P., Cleveland, W., and Dudley, R., eds.), Belmont: Wadsworth International Group.

    Google Scholar 

  10. Poon, T.C.W., Chan, A.T.C., Zee, B., Ho, S.K.W., Mok, T.S.K., Leung, T.W.T., et al. (2001) Application of classification tree and neural network algorithm to the identification of serological liver marker profiles in the diagnosis of hepatocellular carcinoma. Oncology 61:275–283.

    Article  PubMed  CAS  Google Scholar 

  11. Markey, M.K., Tourassi, G.D., and Floyd Jr, C.E. (2003) Decision tree classification of proteins identified by mass spectrometry of blood serum samples from people with and without lung cancer. Proteomics 3:1678–1679.

    Article  PubMed  CAS  Google Scholar 

  12. Chan, A.T.C., Teo, P.M.L., Nagan, R.K., Leung, T.W., Lau, W.H., Zee, B., et al. (2002) Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locaregionally advanced nasopharyngeal carcinoma: progression free survival analysis of a phase III randomized trial. J. Clin. Oncol. 20:2038–2044.

    Article  PubMed  CAS  Google Scholar 

  13. Radmacher, M.D., McShane, L.M., and Simon, R. (2002) A paradigm for class prediction using gene expression profiles. J. Comput. Biol. 9:505–511.

    Article  PubMed  CAS  Google Scholar 

  14. Al-Sarraf, M., LeBlanc, M., Giri, P.G. Fu, K.K., Cooper, J., Vuong, T., et al. (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J. Clin. Oncol. 16:1310–1317.

    PubMed  CAS  Google Scholar 

  15. Chan, A.T.C., Lo, Y.M.D., Zee, B., Chan, L.Y.S., Ma, B.B.Y., Leung, S.F., et al. (2002) Plasma Epstein-Barr virus DNA and residual disease after radiotherary after radiotherapy for undifferentiated carcinoma. J. Natl. Cancer. Inst. 94:1614–1619.

    PubMed  CAS  Google Scholar 

  16. Diamandis, E.P. (2003) Proteomic patterns in biological fluids: do they represent the future of diagnostics? Clin. Chem. 49:1272–1275.

    Article  PubMed  CAS  Google Scholar 

  17. Diamandis, E.P. (2004) Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. J. Natl. Cancer Inst. 96:353–256.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anthony T. C. Chan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Poon, T.C.W., Chow, S.M., Ma, B.B.Y. et al. Serum proteomic pattern for predicting recurrence of undifferentiated nasopharyngeal carcinoma after radiotherapy. Clin Proteom 1, 365–373 (2004). https://doi.org/10.1385/CP:1:3-4:365

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/CP:1:3-4:365

Key Words